Skip to main content


1. Communication from the ASGE Standard of Practice Committee. Ethnic issues in
endoscopy. Gastrintest Endosc 2010;71(7): 1108-12.
Sonnenberg A, Lash RH, Genta RM.: A National Study of Helicobactor pylori
Infection in Gastric Biopsy Specimens. Gastroenterology 2010;139:1894-901.
Enders K. Ng, Wu DC, Uedo N, Gotoda T, Goh KL, Kachintorn U et al.: Risk Factors
Predicting Presence of Intestinal Metaplasia and Dysplasia in Stomach: Findings of a

Multicenter Gastroscopy Screening Study in the Asia Pacific Region.
Gastroenterology 2010;138 (S1): 292-93.
Kochhar R, Poornachandra KS, Dutta U, Agrawal A, Singh K.: Early endoscopic
balloon dilation in caustic-induced gastric injury. Gastrointest Endosc 2010;71(4):737-
Kawamura M, Abe S, Oikawa K, Terai S, Saito M, Shibuya D et al. Topographic
differences in gastric micromucosal patterns observed by magnifying endoscopy with
narrow band imaging. J Gastroenterol Hepatol 2010 Oct 18.[Epub ahead of print] 6.
Rich A, Toro TZ, Tanksley J, Fiske WH, Lind CD, Ayers GD et al.: Distinguishing
Ménétrier’s disease from its mimics. Gut 2010;59(12):1617-24.
Kuo P, Pieterse S, Harley HA.: The Stomach That “Cracked” Under Pressure.
Gastroenterology 2010;138:44-45.
Hokama A, Taira K, Yamamoto Y, Kinjo N, Kinjo F, Takahashi H et al.
:Cytomegalovirus gastritis. World J Gastrointest Endosc 2010;2(11):379-80.
Wu D-C., Hsu P-I., Wu J-Y.: Sequential and concomitant therapy with four drugs is
equally effective for eradication of H. pylori infection Clin Gastroenterol Hepatol
Zullo A., Hassan C., Cristofari F. et al..: Effects of Helicobacter pylori ereadication on
early stage gastric mucosa-associated lymphoid tissue lymphoma Clin Gastroenterol
Hepatol 2010;8:105110
Bao Y.,Spiegelman D., Li R.: History of peptic ulcer diesease and pancreatic cancer
risk in men Gastroenterology 2010;138:541-49
Sethy P. Goenka M., Majumer S.: Helicobacter negativity in NSAID negative peptic
ulcers: increasing trend form India Amer J Gastroenterol 2010;105 (Suppl 1):S31
Ford AC., Thabane M., Collins SM.: Prevalence of univestigated dyspepsia 8 years
after a large waterborne outbreak of bacterial dysentery: a cohort study
Gastroenterology 2010;138:1727-36
Zagari RM., Law GR., Fuccio L. et al..: Epidemiology of functional dyspepsia and
subgroups in the Italian general population: An endoscopic study Gastroenterology
15. Communication from the ASGE Standard of Practice Committee. The role of
endoscopy in the management of patients with peptic ulcer disease. Gastrintest Endosc
2010;71(4): 663-68.
Yang Y-X. Metz DC.: Safety of proton pump inhibitor exposure Gastroenterology
Corley DA., Kubo A., Zhao W., Quesenberry C.: Proton pump inhibitors and
histamine-2 receptor antagonists are associated with hip fractures among at-risk
patients Gastroenterology 2010;138:93-101
Cardinal L., Shankar U., Sharma S. et al.: Systematic review and synthesis: a proton
pump inhibitor exposure duration and association with hip fracture Am J
Gastreoenterol 2010;105 (Suppl.1.):S29-30
Ditah I., Kutait A., Janarthanan S. et al.: Do proton pump inhibitors increase the risk
of bone fractures? A meta-analysis of 14 observational studies Am J Gastroenterol
2010;105(Suppl 1):S40
Targownik LE., Lix LM., Leslie WD.: Proton-pump inhibitor use is not associated with
osteoporosis or accelerated bone minaral density loss Gastroenterology
Wu C-Y., Chan F K-L., Wu M-S. et al.: Histamine2-receptor antagonists are an
alternative to proton pump inhibitor in patients receiving clopidogrel Gastroenterology

22. Lombardo L., Foti M, Ruggia O., Chiecchio A.: Increased incidence of small intestine
bacterial overgrowth durong proton pump inhibitor therapy Clin Gastreonterol Hepatol
Chey WD.: Proton pump inhibitors, irritable bowel syndroma, and small intestinal
bacterial overgrowth: coincidence or Newton’s third law revisted? Clin Gastroenterol
Hepatol 2010;8:480-2
Huang E., Strate L., Ho W. et al.: A prospective study of aspirin use and the risk of
gastrointestinal bleeding in men Am J Gastroenterol 2010;105(Suppl 1):S33
Vilaichone R., Janprampree K., Mahachai V. et al.: Risk of gastrointestinal bleeding
in NSAIDs users with Helicobacter pylori infection in Thailand Am J Gastroenterol
Sung JJY., Lau JYW., Ching JYL et al.: Continuation of low-dose aspirin therapy in
peptic ulcer bleeding Ann Intern Med 2010;152:1-20
Anjiki H, Kamisawa T, Sanaka M, Ishii T, Kuyama Y.: Endoscopic hemostasis
techniques for upper gastrointestinal hemorrhage: A review. World J Gastrintest
Endosc 2010; 16(2): 54-60.
Lau J, Sung JY.: From Endoscopic Hemostasis to Bleeding Peptic Ulcers: Strategies to
Prevent and Treat Recurrent Bleeding. Gastroenterology 2010;138:1252-54.
Wai Yan Chiu P, Yao Yiu Sung J.: High Risk Ulcer Bleeding: When Is Second-Look
Endoscopy Recommended? Clin Gastroenterol Hepatol 2010;8:651-54.
Maiss J, Schwab D, Ludwig A, Naegel A, Ende A, Hahn G et al.: Medical and
endoscopic treatment in peptic ulcer bleeding: a national German survey. Z
Gastroenterol 2010;48(2):246-55.
Nguyen GC, Dinani AM, Pivovarov K:. Endoscopic management and outcomes of
pregnant women hospitalized for nonvariceal upper GI bleeding: a nationwide
analysis. Gastrointest Endosc 2010;72(5):954-59.
Barkun AN, Bardou M, Martel M, Gralnek IM, Sung JJ.: Prokinetics in acute upper GI
bleeding: a meta-analysis. Gastrointest Endosc 2010;72(6):1138-45.
Farooq FT, Lee MH, Das A, Dixit R, Wong RC.: Clinical triage decision vs risk scores
in predicting the need for endotherapy in upper gastrointestinal bleeding. Am J Emerg
Med 2010 Dec 23. [Epub ahead of print] 34.
Sung JJ, Lau, JY, Ching J, Wu JC, Lee YT, Chiu PW et al.: Continuation of low-dose
aspirin therapy in peptic ulcer bleeding: a randomized trial. Ann Intern Med
Egger K, Allescher HD.: Antiplatelet therapy during gastrointestinal bleeding: risk or
benefit? Gastroenterology 2010;139(2):687-89.
Cheng LF, Wang ZQ, Li CZ, Lin W, Yeo AET, Jin B.: Low Incidence of Complications
From Endoscopic Gastric Variceal Obturation With Butyl Cyanoacrylate. Clin
Gastroenterol Hepatol 2010;8:760–66.
Zhu H, Shi B, Upadhyaya M, Wu Z, Lin X, Wu Y, Chen K: Therapeutic endoscopy
of localized gastric varices: pretherapy screening and posttreatment evaluation
with MDCT portography. Abdom Imag
(2010) 35:15-22
Kodashima S., Miki K., Fujishiro M et al.: Usefulness of a new gastric cancer
screening program using the combination assay of serum Helicobacter pylori IgG
antibody and the serum pepsinogen levels Am J Gastroenterol 2010;105(Suppl
Capelle LG., Van Grieken NCT., Lingsma HF. et al.: Risk and epidemilogical time
trends of gastric cancer in Lynch syndrome carriers in the Netherlands
Gastroenterology 2010;138:487-92

40. Song HJ., Srivastava A., Lee J et al.: Host inflammatory response predicts survival
of patients with Epstein-Barr virus-associated gastric carcinoma Gastroenterology
Steevens J., Van den Brandt PA., Goldbohm RA., Schouten LJ.: Selenium status
and the risk of esophageal and gastric cancer subtypes: the Netherland Cohort
Study Gastroenterology 2010;138:1704-13
Raftopoulos SC, Segarajasingam DS, Burke V, Ee HC, Yusoff IF.: A cohort study
of missed and new cancers after esophagogastroduodenoscopy. Am J
Gastroenterol 2010;105(6):1292-97.
Lee TH, Cho JY, Chang YW, Kim JO, Lee JS, Cho WY et al.: Appropriate
indications for endoscopic submucosal dissection of early gastric cancer according
to tumor size and histologic type. Gastrointest Endosc 2010;71(6):920-26.
Kang HY, Kim SG, Kim JS, Jung HC, Song IS.: Clinical outcomes of endoscopic
submucosal dissection for undifferentiated early gastric cancer. Surg Endosc
Lee CK, Chung IK, Lee SH, Kim SP, Lee SH, Lee TH et al.: Is endoscopic forceps
biopsy enough for a definitive diagnosis of gastric epithelial neoplasia? J
Gastroenterol Hepatol 2010;25(9):1507-13.
Kim YJ, Park JC, Kim JH, Shin SK, Lee SK, Lee YC et al.: Histologic diagnosis
based on forceps biopsy is not adequate for determining endoscopic treatment of
gastric adenomatous lesions. Endoscopy 2010;42(8):620-26.
Sumiyama K, Tajiri H, Gostout CJ, Kawamura M, Imazu H, Ohya TR et al.:
Chemically assisted submucosal injection facilitates endoscopic submucosal
dissection of gastric neoplasms. Endoscopy 2010;42(8):627-32.
Kim CG, Choi IJ, Lee JY, Cho SJ, Park SR, Lee JH et al.: Covered versus
uncovered self-expandable metallic stents for palliation of malignant pyloric
obstruction in gastric cancer patients: a randomized, prospective study.
Gastrointest Endosc 2010;72(1):25-32.
Kato M, Nishida T, Tsutsui S, Komori M, Michida T, Yamamoto K et al.:
Endoscopic submucosal dissection as a treatment for gastric noninvasive
neoplasia: a multicenter study by Osaka University ESD Study Group. J
Gastroenterol 2010 Nov 25. [Epub ahead of print]

50. Fernández-Esparrach G, Sendino O, Solé M, Pellisé M, Colomo L, Pardo A et al.:
Endoscopic ultrasound-guided fine-needle aspiration and truecut biopsy in the
diagnosis of gastric stromal tumors: a randomized crossover study. Endoscopy
Enomoto S, Maekita T, Ohata H, Yanaoka K, Oka M, Ichinose M.: Novel risk
markers for gastric cancer screening: Present status and future prospects. World
Journal of Gastrointest Endosc 2010; 16; 2(12): 381-87.
Moschetta M, Stabile Ianora AA, Anglani A, Marzullo A, Scardapane A, Angelelli
Preoperative T staging of gastric carcinoma obtained by MDCT vessel probe
reconstructions and correlations with histological findings. Eur Radiol 2010;20:
Pan Z, Zhang H, Yan Ch, Du L, Ding B, Song Q, Ling H, Huang B, Chen K:
Determining gastric cancer resectability by dynamic MDCT. Eur Radiol 2010;20:
Lee IJ, Lee JM, Kim SH, Shin Ch, Lee JY, Kim SH, Han JK, Choi BI: Diagnostic
Performance of 64-Channel Multidetector CT in the Evaluation of Gastric Cancer:
Differentiation of Mucosal Cancer (T1a) from Submucosal Involvement (T1b and
T2). Radiology 2010;255:805-814.
Chen C-Y, Jaw T-S, Wu D-C, Kuo Y-T, Lee C-H, Huang W-T, Liu G-C: MDCT of
Giant Gastric Folds: Differential Diagnosis. AJR 2010; 195:1124-1130
Tan CH, Peungjesada S, Charnsangavej C, Bhosale P: Gastric Cancer: Patterns of
Disease Spread via the Perigastric Ligaments Shown by CT. AJR 2010; 195:398-
Johnson PT, Horton KM, Fishman EK: Hypervascular Gastric Masses: CT
Findings and Clinical Correlates. AJR 2010; 195:W415-W420
Biondi A, Persiani R, Cananzi F, Zoccali M et al.: R0 resection in the treatment of
gastric cancer: room for improvement. World J Gastroenterol. 2010;
Sharpe D, Williams RN, Ubhi SS, Sutton CD etal.: The „two-week wait” referral
pathway allows prompt treatment but does not improve outcome for patients with
oesophago-gastric cancer. Eur J Surg Oncol. 2010;36(10):977-81
Jensen LS, Nielsen H, Mortensen PB, Pilegaard HK et al.: Enforcing
centralization for gastric cancer in Denmark. Eur J Surg Oncol. 2010;36 Suppl
Sierzega M, Kolodziejczyk P, Kulig J; Polish Gastric Cancer Study Group. Impact
of anastomotic leakage on long-term survival after total gastrectomy for carcinoma
of the stomach. Br J Surg. 2010;97(7):1035-42.
Yonemura Y, Endou Y, Sasaki T, Hirano M et al.: Surgical treatment for peritoneal
carcinomatosis from gastric cancer. Eur J Surg Oncol. 2010 ec;36(12):1131-8.
Glehen O, Gilly FN, Arvieux C, Cotte E et al.: Peritoneal carcinomatosis from
gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive
surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg
Oncol. 2010;17(9):2370-7.
La Torre M, Ferri M, Giovagnoli MR, Sforza N et al.: Peritoneal wash cytology in
gastric carcinoma. Prognostic significance and therapeutic consequences. Eur J
Surg Oncol. 2010;36(10):982-6.
Roviello F, Pedrazzani C, Marrelli D, Di Leo A et al.: Super-extended (D3)
lymphadenectomy in advanced gastric cancer. Eur J Surg Oncol. 2010;36(5):439-

66. Sun Z, Xu Y, Li de M, Wang ZN et al.: Log odds of positive lymph nodes: a novel
prognostic indicator superior to the number-based and the ratio-based N category
for gastric cancer patients with R0 resection. Cancer. 2010; 1;116(11):2571-80.
Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ.: Surgical
treatment of gastric cancer: 15-year follow-up results of the randomised
nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11(5):439-49.
Zhang H, Liu C, Wu D, Meng Y. et al.: Does D3 surgery offer a better survival
outcome compared to D1 surgery for gastric cancer? A result based on a hospital
population of two decades as taking D2 surgery for reference. BMC Cancer
Saito H, Kuroda H, Matsunaga T, Fukuda K et al.: Prognostic indicators in nodenegative advanced gastric cancer patients. J Surg Oncol. 2010;1;101(7):622-5.
Schuhmacher C, Gretschel S, Lordick F, Reichardt P. et al.: Neoadjuvant
chemotherapy compared with surgery alone for locally advanced cancer of the
stomach and cardia: European Organisation for Research and Treatment of Cancer
randomized trial 40954
. J Clin Oncol. 2010;10;28(35):5210-8.
Dikken JL, Jansen EP, Cats A, Bakker B. et al.: Impact of the extent of surgery
and postoperative chemoradiotherapy on recurrence patterns in gastric cancer. J
Clin Oncol. 2010;10;28(14):2430-6.
Kim HH, Hyung WJ, Cho GS, Kim MC. et al.: Morbidity and mortality of
laparoscopic gastrectomy versus open gastrectomy for gastric cancer: an interim
report–a phase III multicenter, prospective, randomized Trial (KLASS Trial). Ann
Surg. 2010;251(3):417-20.
Kodera Y, Fujiwara M, Ohashi N, Nakayama G. et al.: Laparoscopic surgery for
gastric cancer: a collective review with meta-analysis of randomized trials. J Am
Coll Surg. 2010;211(5):677-86.
Yamamoto H, Kojima A, Miyasaka Y, Imamura M. et al.: Prognostic impact of
blood vessel invasion in gastrointestinal stromal tumor of the stomach. Hum
Pathol. 2010;41(10):1422-30.
Maor Y, Avidan B, Melzer E, Bar-Meir S.: Long-term clinical outcome of patients
with gastric gastrointestinal stromal tumors. Dig Dis Sci. 2010;55(10):2893-8.
Krejs GJ.: Gastric cancer: epidemiology and risk factors Dig Dis. 2010;28(4-
5):600-3. Epub 2010 Nov 18
Lázár DA.r, S. Tabán, I. Sporea et al.: Ki-67 expression in gastric cancer. Results
from a prospective study with long-term follow-up Romanian Journal of
Morphology and Embryology 2010;51(4):655–661
Okines A., M. Verheij, W. Allum et al.: Gastric cancer: ESMO Clinical Practice
Guidelines for diagnosis, treatment and follow-up (On behalf of the ESMO
Guidelines Working Group) Annals of Oncology 2010;21 (Supplement 5):50–54:
Washington K.: 7th Edition of the AJCC Cancer Staging Manual: Stomach Ann
Surg Oncol 2010;17:3077-3079
Ma Y., Y- Xue ,Y. Li et al.: Subclassification of Stage IV Gastric Cancer (IVa, IVb,
and IVc) and Prognostic Significance of Substages J Gastrointest Surg
The GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International
Collaboration) Group
Benefit of Adjuvant Chemotherapy for Resectable Gastric
Cancer A Meta-analysis JAMA. 2010;17:1729-1737

82. Kulig J. P. Kolodziejczyk M. Sierzega et al.( Polish Gastric Cancer Study
Adjuvant Chemotherapy with Etoposide, Adriamycin and Cisplatin
Compared with Surgery Alone in the Treatment of Gastric Cancer: A Phase III
Randomized, Multicenter, Clinical Trial Oncology; 2010;78:54–61
Bamias A., M. Karina, P. Papakostas et al.: A randomized phase III study of
adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in
patients with gastric cancer Cancer Chemother Pharmacol 2010;65:1009–1021
Kwon H-C., MC Kim, KH Kim et al.: Adjuvant chemoradiation versus
chemotherapy in completely resected advanced gastric cancer with D2 nodal
dissection Asia–Pacific Journal of Clinical Oncology 2010;6
: 278–285
Mezhir JJ., LH Tang et al: Neoadjuvant Therapy of Locally Advanced Gastric
Cancer Journal of Surgical Oncology 2010;101:305–314
Ajani JA., W. Rodriguez, Gy. Bodoky, et al.: Multicenter Phase III Comparison of
Cisplatin/S-1 With Cisplatin/Infusional Fluorouracil in Advanced Gastric or
Gastroesophageal Adenocarcinoma Study: The FLAGS Trial J Clin Oncol
Kulka J., I Szirtes, AM Szász, P Kupcsulik, I Kenessey, G Lotz, J Tímár: A
gyomorrák kezelésének aktualitásai: A gyógyszeres kezelés patológiai alapjai és
háttere, minőségbiztosítás a patológiában Magyar Onkológia 2010;54:343–350
Bang YJ., E Van Cutsem A Feyereislova et al.: Trastuzumab in combination with
chemotherapy versus chemotherapy alone for treatment of HER2-positive
advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, openlabel, randomised controlled trial The Lancet, 2010;28: 687 – 697
Tebbutt NC., MM Cummins et al.: Australasian Gastro-Intestinal Trials Group
Randomised, non-comparative phase II study of weekly docetaxel with cisplatin
and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG
ATTAX trial British Journal of Cancer 2010;102, 475 – 481
Yun J., J-Lee,.Se Hoon Park, et al.: A randomised phase II study of combination
chemotherapy with epirubicin, cisplatin and capecitabine (ECX) or cisplatin and
capecitabine (CX) in advanced gastric cancer European Journal of Cancer
Kim JY., YR Do ,KU. Park et al: Multicenter phase II trial of S-1, paclitaxel and
cisplatin triplet combination chemotherapy in patients with advanced gastric
Cancer Cancer Chemother Pharmacol 2010; 67:527–532 (2011) online pub
Gubanski M., A Johnson, E Fernebro et al: Randomized phase II study of
sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in
patients with advanced gastric cancer: the GATAC trial Gastric Cancer 2010;13:
Wang DL., DY Gu, HY Huang et al.: Irinotecan-involved regimens for advanced
gastric cancer: A pooled-analysis of clinical trials World J Gastroenterol 2010;16
(46): 5889-5894
Rao S., N. Starling,D. Cunningham et al: Matuzumab plus epirubicin, cisplatin and
capecitabine (ECX) compared with epirubicin, cisplatin and capecitabine alone as
first-line treatment in patients with advanced oesophago-gastric cancer: a
randomised, multicentre open-label phase II study Annals of Oncology 2010;21:
Lordick F., B Lube, S Lorenzen et al.: Cetuximab plus oxaliplatin/leucovorin/5-
fluorouracil in first-line metastatic gastric cancer: a phase II study of the
Arbeitsgemeinschaft Internistische Onkologie (AIO) British Journal of Cancer
2010;102: 500-505

96. Sun W., M. Powell, J. O’Dwyer, P Catalano, R H. Ansari, Al B. Benson: III Phase
II Study of Sorafenib in Combination With Docetaxel and Cisplatin in the
Treatment of Metastatic or Advanced Gastric and Gastroesophageal Junction
Adenocarcinoma: ECOG 5203 J Clin Oncol 2010;28:2947-2951
Bang YJ. ,YK Kang,WK. Kang et al.: Phase II study of sunitinib as second-line
treatment for advanced gastric cancer Invest New Drugs 2010 May 12.
Doi T., K. Muro, N. Boku, et al.: Multicenter Phase II Study of Everolimus in
Patients With Previously Treated Metastatic Gastric Cancer J Clin Oncol
Reddymasu SC., Sarosiek I., McCallum W.: Severe gastroparesis: medical therapy
of gastric electrical stimulation Clin Gastroenterol Hepatol 2010;8:117-24
McCallum RW., Snape W., Brody F.: Gastric electrical stimulation with
Enterra therapy improves symptoms from diabetic gastroparesis in prospective
study Clin. Gastroenterol Hepatol 2010;8:947-54
Tavakkoli A., Talley N., Baldwin D. et al.: Gastroparesis is not associated
with acid or nonacid reflux Am J Gastroenterol 2010;105(Suppl 1):S32
Roberts-Thomson IC, Singh R, Edward T, Nguyen NQ, Lidums I.: The
future of endoscopy. J of Gastroenterol and Hepatol 2010;25:1051–57.
Bnerjee S, Jay P.: Embracing New Technology in the Gastroenterology
Practice. Clin Gastroenterol Hepatol 2010;8:848–50.
Curvers WL, Herrero LA, Wallace MB, Wong Kee Song LM, Ragunath K,
Wolfsen HC et al.:
Endoscopic Tri-Modal Imaging Is More Effective Than
Standard Endoscopy in Identifying Early-Stage Neoplasia in Barrett’s Esophagus.
Gastroenterology 2010;139:1106–14.
Kochhar R, Kochhar S.: Endoscopic balloon dilation for benign gastric
outletobstruction in adults. World J Gastrointest Endosc 2010;16; 2(1): 29-35.
Hijikata Y, Ogasawara N, Sasaki M, Mizuno M, Masui R, Tokudome K et
Endoscopic submucosal dissection with sheath-assisted counter traction for
early gastric cancers. Dig Endosc 2010;22(2):124-28.
Parra-Blanco A, Arnau MR, Nicolás-Pérez D, Gimeno-García AZ,
González N, Díaz-Acosta et al.:
Endoscopic submucosal dissection training with
pig models in a Western country. World J Gastroenterol. 2010;21;16(23):2895-
Hu CT.: Gauze pledgetting versus endoscopic-guided aerosolized spray for
nasal anesthesia before transnasal EGD: a prospective, randomized study
Gastrointest Endosc 2010;71(1):11-20.
Ibrahim M, Blero D, Deviere J.: Endoscopic options for the treatment of
obesity. Gastroenterology 2010;138:2228-32.
De Jong K, Mathus–Vliegen EMH, Weldhuyzen EAML, et al.: Shortterm
safety and efficacy of the transoral endoscopic restrictive implant system for the
treatment of obesity. Gastrointest Endosc [in press].
Schigt A, Scholten P, van Wagensveld BA.: Is There a Place for
Preoperative Gastroscopy in Morbidly Obese Patients Undergoing Gastric Bypass
Surgery? Gastroenterology 2010;138 (S1): 389.
Fernandez-Esparrach G, Lautz DB, Thompson CC.: Endoscopic repair of
gastrogastric fistula after Roux-en-Y gastric bypass: a less-invasive approach. Surg
Obes Relat Dis 2010;6(3):282-88.
Bhardwaj A, Cooney RN, Wehrman A, Rogers AM, Mathew A.: Endoscopic
repair of small symptomatic gastrogastric fistulas after gastric bypass surgery: a
single center experience. Obes Surg 2010;20(8):1090-95.

114. Campos JM, Evangelista LF, Galvão Neto MP, Ramos AC, Martins JP, dos
Santos MA Jr. et al.:
Small erosion of adjustable gastric band: endoscopic removal
through incision in gastric wall. Surg Laparosc Endosc Percutan Tech
Campillo-Soto A, Torralba-Martínez JA, Martín-Lorenzo JG, Lirón-Ruiz R,
Bento-Gerard M, Pérez-Cuadrado E et al.:
Gastrojejunal anastomosis stricture
after laparoscopic gastric bypass. Our experience with 62 patients. Rev Esp
Enferm Dig 2010;102(3):187-92
Himpens J, Dobbeleir J, Peeters G.: Long-term results of laparoscopic
sleeve gastrectomy for obesity. Ann Surg. 2010;252(2):319-24
Xiao C., Ogle SA., Schumacher MA. et al.: Loss of parietal cell expression of
Sonic Hedghog induces hypergastrinaemia and hyperproliferation of surface mocous
cells Gastroenterology 2010;138:550-561
Waghray M., Zavros Y., Saqui-Salces M. et al.: Interleukin-1β promotes gastric
atrophy through suppression of Sonic Hedgehog Gastroenterology 2010;138:562-72
Van Dop WA., Van den Brink GR.: Sonic Hedgehog: A link between
inflammation, gastric atrophy, and acid suppression? Gastroenterology 2010;138:426-
Merriman NA, Putt ME., Yang Y-X.: Hip fracture risk in patients with a
diagnosis of pernicious anaemia Gastroenterology 2010;138:1330-7
Adachi S., Takiguchi S., Okada K. et al.: Effects of ghrelin administration
after total gastrectomy: A prospective, randomized, placebo-controlled phase II.
study Gastroenterology 2010;138:1312-20
Curcic J, Fox M, Kaufman E, Forras-Kaufman ZS, Hebbard GS, Roy S, Pal
A, Schwizer W, Fried M, Treier R, Boesiger P:
Gastroesophageal Junction:
Structure and Function as Assessed by Using MR Imaging. Radiology
123. de Zwart IM, de Roos A: MRI for the evaluation of gastric physiology. Eur
Radiol (2010) 20: 2609-2616
Mine S, Sano T, Tsutsumi K, Murakami Y et al.: Large-scale investigation
into dumping syndrome after gastrectomy for gastric cancer. J Am Coll Surg.
Nau P, Ellison EC, Muscarella P Jr, Mikami D et al.: A review of 130
humans enrolled in transgastric NOTES protocols at a single institution. Surg
Endosc. 2010 Oct 26. [Epub ahead of print]